|
See also: ,
Pioneer Perspective
Of Microbes & Molecules
by Kim MacQueen & Frank Stephenson
A Young Program Holds Promise For Putting FSU At The Forefront Of New
Research Into The Terribly Complex Chemistry Of Life.
Toward the Form of Function
Biology's Final Frontier
It's been called the Star Trek of basic research. The Human Genome Project,
launched in 1990 by the National Institutes of Health and the U.S.
Department of Energy, is a quest for unprecedented knowledge of the
fundamental elements of human life. This $3 billion, 15-year mission will
take scientists into the far reaches of genetics, where the basic secrets
of chromosomal cause-and-effect lie buried in a biochemical web.
The ultimate goal of this massive, international research campaign is to
determine the intricate layout of the chemical building blocks making up
the foundations of every human gene. Given that humans possess at least
100,000 genes, a mass of DNA molecules configured with three billion
distinct "blocks," the task is easily the most daunting challenge genetic
scientists have ever faced.
When completed around 2005, these scientists hope to have a complete
blueprint of the entire human genetic code, a vast assemblage of
information detailing the precise order of the chemical units that make
each human gene unique. Such a feat, say scientists, will be analogous to
determining the sequence of letters making up every book in a large
library.
Aside from being one of the first technological triumphs likely to be
hailed in the next century, what will such an accomplishment mean? Once
the exact order, or sequence, of all three billion genetic units are known,
what then? Geneticists readily admit that knowing how a gene is chemically
configured, or "sequenced," is only the faintest first step toward knowing
how it works, the ultimate goal of all genetics research.
Scientists generally agree that the end of the Human Genome Project will
mark the beginning of the really heavy lifting in the protracted battle to
understand how DNA and other molecules do the incredible things they do
within the confines of living things. With the complete genetic "map" in
hand, the job becomes one of "reading" the vast, newly ordered blueprint
and making sense of it all. But hopefully by then, the job will be
somewhat easier, thanks to impressive gains now being made in a young field
known as structural biology.
An outgrowth of the familiar-sounding field of molecular biology,
structural biology is now recognized as the key research specialty setting
the pace for advancement in a host of high technologies, from
bioengineering to gene therapy. Biological research centers the world over
are rapidly beefing up their profiles in the field amid near-daily news
accounts of remarkable developments stemming from discoveries made in
structural biology labs.
Florida State is no exception. In 1990, the university's Institute of
Molecular Biophysics (IMB), formally organized a structural biology
program, the institute's newest initiative in the past decade.
Jump-started with a $4 million gift from the Miami-based Lucille P. Markey
Charitable Trust, the program-with seven full-time faculty researchers-now
is the largest program of its kind in the Southeast.
Also helping the new program jump directly into the fore of formidable
competition coming from more well-established research centers around the
country is its close tie with the National High Magnetic Field Laboratory,
headquartered at nearby Innovation Park in Tallahassee. This $100 million
enterprise, in full operation since 1993, is equipped with some of the
latest and most powerful diagnostic tools in the world, machines enormously
important for structural biology research.

Dr. Lee Makowski (Ph.D. MIT), IMB director since 1993, has helped
orchestrate the program's rapid development, guided by FSU's traditional
strengths in physics, biology and chemistry-the three principle disciplines
which converge in structural biology. Makowski is convinced that the field
is becoming increasingly critical in the transfer of knowledge derived from
basic, life-science research to practical applications in medicine and
industry.
"The driving force behind structural biology is the fact that it is very
difficult to understand how a complicated machine works if you can't see a
picture of it working," Makowski says. "We can now produce that picture,
down to the level of every single atom, and use it to focus on questions
that can make a difference in people's lives."
Though it didn't get its name until the late 1950s, structural biology is
a direct descendant of the startling 1953 discovery of the
three-dimensional (3-D) shape of the DNA molecule. Two Cambridge
University researchers, James Watson and Francis Crick, awed the scientific
world that year when they unveiled the exquisite symmetry of the moledule's
gracefully coiled, double-helix structure.
For the first time, biologists had clear, unshakable evidence that the
physical, 3-D structure of life's most important molecule plays a profound
role in its crucial and extremely varied functions. Scientists soon began
to see direct links between the shapes and sizes of all DNA-based molecules
and the behavior of the microscopic "organs" -such as cells and cell
parts-that these molecules make up in plants and animals.
With tools available to them today that Watson and Crick might never have
imagined, structural biologists are adding layer upon layer of knowledge to
a growing body of insight into the relationship between the 3-D form of
biological molecules and their function. The young human genome effort,
with its thrilling, fallout discoveries of such things as faulty genes
responsible for a number of human ills, may have grabbed most of the
headlines, but the fact is that structural biology is playing equally
important roles in many other avenues of research.
At FSU, most of the focus is on determining the 3-D characteristics of the
large molecules which serve as the building blocks for such things as cell
membranes, muscle fibers and viruses. Just as a house is dependent on its
foundation, walls, and roof to serve its function, so do each of these
structures depend on an intricate framework of interlocking molecules that
governs its development.
Most of the molecules under study at FSU, and indeed in most structural
biology research, belong to a special group called macromolecules, so-named
because of their enormous sizes. Since life itself is based on a
macromolecule-DNA-it's not surprising that almost all of the complex
organic chemicals necessary for life-primarily proteins-belong to this
family of molecular giants, some of which have upwards of 100,000 atoms
embedded in their molecular skeletons.
Since proteins are the engines that drive every biological process
imaginable, even from its earliest beginnings structural biology has been
focused on a quest to link proteins' 3-D frameworks to their myriad
functions. Indeed, whatever gains come from the Human Genome Project are
likely to be measured by what scientists learn about the way gene
sequencing dictates proteins' structure. How genes are sequenced
determines everything about how proteins are built, which in turn
determines how they drive everything from cell division to thinking.
Last year, FSU hired a scientific pioneer who has spent most of his career
studying protein structure, and particularly how it figures into the
creation of what is arguably mankind's sturdiest foe-viruses.
Dr. Donald L.D. Caspar (Ph.D. Yale), left a post at Brandeis University to
join IMB's new Program in Structural Biology. A member of the National
Academy of Science, Caspar is an internationally recognized figure in
structural biology, and in fact is credited with giving the field its name
(see related article). His work on virus structure is generally regarded
as having established the fundamental principals underlying these
fascinating organisms' molecular architecture, Makowski said.
Makowski feels that the presence of Caspar not only helps put IMB on the
scientific map but also goes a long way toward attracting top-flight
researchers. Just this fall, the IMB team drew to FSU another prominent
specialist in determining protein structure, Dr. Kenneth Taylor (Ph.D. UC
Berkeley), formerly of Duke University. Taylor studies the complex
mechanisms in the proteins that make human muscle function possible, using
electron microscopes to obtain 3-D images of the protein's structure.
Taylor is a highly skilled specialist in electron microscopy. Caspar, in
turn, is an innovator of uses for the most powerful X-ray machines on
earth-giant electron accelerators called synchrotrons -in studying the
protein labyrinths of viral structure. Both scientists typify the special
calling that marks all structural biologists-these are scientists who are
entirely dependent on the availability and power of highly specialized
instruments that make their work possible.
The challenge, of course, is to be able to "see" structures that are
nothing but strings of atoms. Even the strongest light microscope is of
little use in determining the shape and movement of molecules, so
biologists must rely on three principal techniques: X-ray crystallography,
in which crystallized bits of organic matter are bombarded with X-rays (see
box above); nuclear magnetic resonance (NMR) spectroscopy and electron
microscopy. When Watson and Crick discovered the double-helical structure
of DNA, some of these techniques were around, but none had the
sophistication of the tools available today.
So it is that structural biologists have become more or less divided into
the camps of the techniques at hand. Such instruments literally allow
scientists to take visual "tours" of macromolecular architecture, "seeing"
individual atoms and their connections with other atoms, and, on a broader
scale, seeing close up the innermost workings of living tissue such as cell
nuclei and muscle fiber.
FSU's Taylor, for example, is using his skills in electron microscopy (EM)
to develope new techniques for producing 3-D images from a single specimen
of living tissue. Already to his credit is a novel, now widely used
technique of studying such specimens that eliminates one of EM's major
drawbacks in such work. Traditionally, EM users faced a dilemma: To study
living tissue, they literally had to embalm it to observe it in the
ultra-high vacuum of the electron microcope. Water, the essential
component of all living systems, was usually replaced by inorganic "stains"
to provide a non-volatile supporting medium. Taylor developed a technique
in which the sample is encased in ice, creating a gentler process that
maintains the molecules in as near their living condition as possible.
The planned arrival next spring of a new high-powered electron microscope
to the institute's on-campus home is another IMB coup. Even with Taylor's
innovative ice technique, EM can be a dicey tool for biologists, because
the electrons these machines fire at targets can damage specimens.
Microscopes generating electron-beam energies of only 100 kilovolts (KeVs),
for example, can tear such specimens apart. At 200 KeVs, the damage is
less, and it's less still at 300 KeV, the power of the machine scheduled to
be installed within IMB. Its arrival, along with a field emission gun
(essentially an electron laser) aimed at studying atomic contrast at the
finest level of detail, will make FSU-based EM second to none in the
business, Makowski says.
For sophisticated X-ray work, FSU researchers such as Caspar aren't likely
to find an instrument they can use in Tallahassee any time soon. Because
of their enormous cost, ultra-high-powered sources of X-rays are confined
primarily to national facilities such as Brookhaven National Laboratory in
New York. Such machines are highly useful in examining the molecular
structure of biological specimens in crystallized form.
If scientists can get a specimen to crystallize, they can bombard it with
high-powered X-rays and hope to get a detailed pattern of X-radiation that
gets reflected off atoms making up the specimen's molecules. Such
patterns can tell researchers precisely where individual atoms lie along a m
olecule's framework, indispensable information for determining its shape.
But it may be NMR spectroscopy that puts IMB's structural biology research
a notch ahead of the competition. The close relationship with the magnet
lab gives IMB access to some of the best, most cutting-edge NMR facilities
available anywhere, Makowski says.
"The NMR facility here is among the best in the world," echoes Dr. Tim
Logan (Ph.D. Chicago), who uses it to study how and why proteins fold into
various 3-D structures, the most vexing problem in the field. "There's a
great core of people there, the support staff is excellent, and they have
some of the best machinery in the world."
That the magnet lab now boasts such a facility is a testimony to the work
of such FSU researchers as Dr. Tim Cross, a chemist and ardent champion of
using NMR techniques in structural biology. When word first spread of
FSU's decision to vie for the federal grant to establish the magnet lab in
1990, Cross collaborated with Dr. Jack Crow, now NHMFL director, on the
proposal to the National Science Foundation. That proposal included a
provision for a 27,000-sq.-ft. facility dedicated exclusively to exploiting
NMR's potential for use in physics, chemistry and particularly in
structural biology. Cross, who served as the structural biology program's
first director, now is director of new intiatives within the NHMFL.
But for all their power and sophistication, the tools in the hands of
today's structural biologists seem almost crude when one considers the
questions posed by even the simplest living organism. How is it that only
a few lifeless elements-mainly oxygen, nitrogen, carbon, hydrogen and
phosphorous-can come together in electrifying ways to create life? How can
it be that seemingly lifeless molecules move? Why do identical genes work
in some places and not in others? Such questions are hardly new, and some
seem as intractable today as they ever did. However, recent advances
suggest promising new approaches to reliable answers.
If nothing else, the rise of applications in biotechnology, a field unheard
of just 20 years ago, has demonstrated the value of basic research in
structural biology. Sick people are being cured today with manmade drugs
built literally an atom at a time, thanks to fundamental knowledge of
molecular structure and behavior. From gene research has sprung gene
therapy, which, although still in its infancy, is a branch of medicine that
many think will revolutionize the diagnosis and treatment of hundreds of
genetically based diseases.
IMB researcher Dr. Michael Chapman (Ph.D. UCLA), is one of many structural
biologists today intrigued by the idea of using viruses, for example, as
therapeutic agents for fighting cancer. He studies the atomic structures
of harmless viruses that might be used as vectors, carrying good copies of
damaged genes and depositing them wherever the body might need them. The
idea is that if a virus can be engineered to carry a good copy of BRCA1-the
gene that researchers have found predisposes women to breast cancer-and
drop it off at the right chromosome without being attacked by the human
immune system first, physicians would have a good chance at stopping breast
cancer before it starts. If they could use this same technique on the gene
that causes muscular dystrophy, adult carriers of this debilitating killer
could arrest it before passing it on to their children.
Chapman also studies the atomic structure of a relative of the human enzyme
creatine kinase, which is responsible for replenishing energy resources
inside such things as heart muscle. Physicians measure for presence of the
enzyme as a way of determining whether a patient has had a heart attack.
Better knowledge of the enzyme's atomic structure will help researchers
design a more reliable clinical diagnosis, Chapman says.
"What all of us are trying to do here," he adds, "is to use an
understanding of molecular structure to improve health."
Poised to tackle a broad range of problems with both excellent facilities
and scholars, the IMB has generatedan environment that appeals not only to
its faculty researchers, but to would-be researchers as well, says
Makowski. The place is abuzz with the enthusiasm of new projects designed
to engage both teacher and student.
"Research is really just the practice of learning, of thinking in a highly
disciplined way," added Makowski. "Since our main goal is to teach our
students to think and to learn, I believe that all students should
participate in research."
The mix of missions-teaching and research-is well-balanced within the IMB,
Caspar feels, another reason he's convinced the program is a good
investment for both FSU and the field of structural biology.
"Resources have gotten much more strained in science during the past
decade," Caspar notes. "As a result, a lot of the projects in structural
studies at other places have rather narrow focuses.
"Here at Florida State, we've got an exceptional opportunity to build up a
new, broad-based program. There are going to be opportunities here to do
novel work in a number of exciting directions."
|